J Otolaryngol Ophthalmol Shandong Univ ›› 2017, Vol. 31 ›› Issue (6): 5-8.doi: 10.6040/j.issn.1673-3770.1.2017.039

Previous Articles     Next Articles

Interpretation of the eighth edition of thyroid cancer tumor-node-metastasis staging by American Joint Committee on Cancer.

QIU Jie1, SUN Shasha2, SUN Yan1   

  1. 1. Department of Otolaryngology &Head and Neck Surgery, Affiliated Hospital of Qingdao University, Qingdao 266003, Shandong, China;2. Department of Postgraduate, Weifang Medical College, Weifang 261053, Shandong, China
  • Received:2017-10-09 Online:2017-12-16 Published:2017-12-16

PDF (PC)

1478

Abstract: The tumor-node-metastasis(TNM)staging system is currently the most common tumor staging system worldwide. After examining tumors, nodes, and metastases(per TNM staging), the corresponding general stages can be determined, namely, stages Ⅰ, Ⅱ, Ⅲ, and Ⅳ. The American Joint Committee on Cancer(AJCC)has developed a TNM staging standard that has been widely recognized and applied. The eighth edition of the tumor TNM staging system released by AJCC will be implemented globally by January 1, 2018. In this paper, the content of the thyroid cancer TNM staging standard in the eighth edition of AJCC and the changes relative to the seventh edition will be interpreted in detail.

Key words: Thyroid cancer, TNM staging, American Joint Committee on Cancer

CLC Number: 

  • R736.1
[1] 刘荫华, 姚宏伟, 周斌,等. 美国肿瘤联合会结直肠癌分期系统(第8版)更新解读[J].中国实用外科杂志, 2017, 37(1):6-9. LIU Yinhua, YAO Hongwei, ZHOU Bin, et al. Updates and interpretations of AJCC cancer staging manual 8th edition for colorectal carcinoma[J].Chin J Prac Surg, 2017, 37(1):6-9.
[2] 孙彦, 王琪. 2002年AJCC甲状腺癌分期方案[J].国际耳鼻咽喉头颈外科杂志,2004, 28(6):385-386.
[3] 孙威, 贺亮, 张浩. 美国癌症联合委员会甲状腺癌分期系统(第8版)更新解读[J].中国实用外科杂志, 2017, 37(3):255-258. SUN Wei, HE Liang, ZHANG Hao. Interpretations on the updates of American Joint Committee on cancer staging system(8th edition)for thyroid cancer[J]. Chin J Prac Surg, 2017, 37(3):255-258.
[4] Kim M, Kim YN, Kim WG, et al. Optimal cutoff age in the TNM staging system of differentiated thyroid cancer: is 55 years better than 45 years?[J].Clin Endocrinol, 2017, 86(3):438-443.
[5] Tuttle RM, Haugen B, Perrier ND. The updated AJCC/TNM staging system for differentiated and anaplastic thyroid cancer(8th edition): what changed and why?[J]. Thyroid, 2017, 27(6):751-756.
[6] Edge SB, Compton CC. The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol, 2010, 17(6):1471-1474.
[7] Edge SB. AJCC cancer staging manual[J]. Jama, 2010, 304(15):1726-1727.
[8] Beahrs OH, Myers MH. American Joint Committee on cancer manual for staging of cancer[M]. 2nd ed. Philadelphia: JB Lippincott, 1983.
[9] Nixon IJ, Wang LY, Migliacci JC, et al. An international multi-institutional validation of age 55 years as a cutoff for risk stratification in the AJCC/UICC staging system for well-differentiated thyroid cancer.[J]. Thyroid, 2016, 26(3):373-380.
[10] Kim M, Kim WG, Oh HS, et al. Comparison of the 7th and 8th editions of the AJCC/UICC TNM staging system for differentiated thyroid cancer[J]. Thyroid, 2017, 27(9):1149.
[11] Kim TH, Kim YN, Kim HI, et al. Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma[J]. Oral Oncol, 2017, 71:81-86.
[12] Beahrs O, Carr DT, Rubin P. American Joint Committee for cancer staging and end results reporting[M]. Manual for Staging of Cancer. Philadelphia, PA: J B Lippincott Co., 1977.
[13] Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol, 2010, 17(6):1471-1474.
[14] Wells SA Jr, Asa SL, Dralle H, et al. Revised American thyroid association guidelines for the management of medullary thyroid carcinoma[J]. Thyroid, 2015, 25(6):567-610.
[15] Jin LX, Moley JF. Surgery for lymph node metastases of medullary thyroid carcinoma: A review[J]. Cancer, 2016, 122(3):358-366.
[16] Boostrom SY, Grant CS, Thompson GB, et al. Need for a revised staging consensus in medullary thyroid carcinoma.[J]. Arch Surg, 2009, 144(7):663-669.
[17] Tuttle RM, Ganly I. Risk stratification in medullary thyroid cancer: moving beyond static anatomic staging[J]. Oral Oncol, 2013, 49(7):695-701.
[18] Yang JH, Lindsey SC, Camacho CP, et al. Integration of a postoperative calcitonin measurement into an anatomical staging system improves initial risk stratification in medullary thyroid cancer[J]. Clin Endocrinol, 2016, 83(6):938-942.
[19] Wang W, Sun XW, Li CF, et al. Comparison of the 6th and 7th editions of the UICC TNM staging system for gastric cancer: results of a Chinese single-institution study of 1,503 patients[J]. Ann Surg Oncol, 2011, 18(4):1060-1067.
[20] Kim TY, Kim WG, Kim WB, et al. Current status and future perspectives in differentiated thyroid cancer[J]. Endocrinol Metab, 2014, 29(3):217-225.
[1] PUBU Ciren, LIU Jifeng, BA Luo. Relationship between thyroid cancer and hematological components of the systemic inflammatory response. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(6): 21-24.
[2] YU Jichun. Neck dissection to differentiated thyroid carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(2): 10-12.
[3] ZHUANG Da-yong, HE Qing-qing, FAN Zi-yi, ZHENG Lu-ming, ZHU Jian, ZHOU Peng, DUAN Song-jian, YUE Tao, DONG Xue-feng. Intra-operative nerve monitoring in re-operation for differentiated thyroid carcinoma [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(6): 5-8.
[4] ZHAO Guo-wei， HE Qing-qing， ZHUANG Da-yong， ZHENG Lu-ming， FAN Zi-yi， ZHU Jian， YU Fang， ZHOU Peng， HOU Lei， JIANG Hui-ping. Benefits and risks of I-131 therapy in patients with differentiated thyroid cancer [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(6): 16-21.
[5] CAO Lei， HE Qing-qing， ZHUANG Da-yong， ZHENG Lu-ming， FAN Zi-yi, ZHOU Peng， ZHU Jian. Low small incision in  total thyroidectomy and selective neck lymphnode dissection [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(2): 56-59.
[6] SUN Zhen-feng, ZHANG Jia, XU Hong-ming, WANG Guo, DONG Pin. Diagnosis and treatment of micro-thyroid cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(1): 44-45.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd